Catalyst Wire Dossier Catalyst Wire Dossier

Sprifermin

sprifermin · Merck KGaA
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Sprifermin, covering 2015-08-31 to 2020-07-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee [Phase 2]

See pricing